LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
LNSR is expected to report earnings to fall 90.37% to -15 cents per share on May 07
Q1'25
Est.
$-0.16
Q4'24
Missed
by $1.43
Q3'24
Beat
by $0.16
Q2'24
Missed
by $0.49
Q1'24
Beat
by $0.10
The last earnings report on February 27 showed earnings per share of -161 cents, missing the estimate of -18 cents. With 97.75K shares outstanding, the current market capitalization sits at 38.71M.